Background
==========

The improvement of *in vitro*maturation (IVM) protocols through the supplementation with different molecules has become an alternative to increase the culture medium efficiency. Tretinoin (TTN, all-*trans*retinoic acid, ATRA), is an active metabolite of vitamin A \[[@B1]\], that mediates cell proliferation, cell differentiation, and embryonic development process. In *in vitro*production embryos systems, TTN acts improving cytoplasmic maturation process in oocytes, developmental competence in early embryos, and quality in blastocysts \[[@B2]\]. Studies have been demonstrated the presence of α, β and γ subtypes of retinoic acid receptors (RARα, RARβ, RAR~γ~) for TTN in oocyte, hatched blastocysts, and cumulus cells \[[@B3]\]. This molecule can also be used for treatment of skin disorders and for anti-tumor treatment, so researchers have been associated TTN with polymeric nanoparticles to protect it from degradation and to improve its chemical stability and efficacy \[[@B4]\]. The aim of present study was to test the concentration-dependent effect of supplementation of free tretinoin (TTN) and tretinoin-loaded lipid-core nanocapsules (TTN-LNC) in bovine *in vitro*maturation media, and its influence in reactive oxygen species (ROS) production in two-to four-cell stage embryos. In conclusion, tretinoin- loaded lipid-core nanocapsules added in *in vitro*maturation media highly protects embryos at early stage of development against oxidative stress.

Methods
=======

The experimental groups were established, and cumulus-oocyte complexes (COCs) were matured in oocyte *in vitro*maturation medium supplemented with 0.25, 0.5 and 1 μM of TTN-LNC or TTN. Control groups of COCs matured without treatment and treated only with blank lipid-core-nanocapsules (LNC) were also examined. The oocytes were *in vitro*fertilized in order to evaluate the ROS levels in embryos produced by the different treatments. The ROS formation was evaluated in two-to four-cell stage embryos as previously described \[[@B5]\] with some modifications.

Results and conclusions
=======================

ROS production was lower in embryos derived from oocytes matured in the presence of TTN or TTN-LNC. Both treatments TTN and TTN-LCNC protect the cell more effectively against oxidative damage reducing the ROS production. A significant reduction (p \<0.05) in ROS production was detected in the presence of TTN-LCNC compared with controls. There was no difference between the concentrations in TTN and TTN-LNC groups. Tretinoin-loaded lipid-core nanocapsules offers an increased protection against oxidative stress in embryos produced *in vitro*. The studies at the molecular level using oocyte competence markers are alternatives to clarify the function of lipid-core nanocapsules in *in vitro*maturation and in embryonic development.
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